Lv7
3310 积分 2020-11-25 加入
Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study
1小时前
待确认
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
1小时前
待确认
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
1小时前
待确认
Risankizumab for Ulcerative Colitis
1小时前
待确认
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
1小时前
待确认
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
2小时前
待确认
Risankizumab for Ulcerative Colitis
3小时前
待确认
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
3小时前
待确认
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
3小时前
待确认
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
3小时前
待确认
皖公网安备34019202002308
